Viking Therapeutics
VKTX
#3666
Rank
โ‚ฌ2.31 B
Marketcap
20,63ย โ‚ฌ
Share price
-6.61%
Change (1 day)
-69.65%
Change (1 year)

EPS for Viking Therapeutics (VKTX)

EPS in 2023 (TTM): -0,86ย โ‚ฌ

According to Viking Therapeutics 's latest financial reports the company's current EPS (TTM) is -0,85ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -0,83ย โ‚ฌ a decrease over its 2021 EPS that were of -0,66ย โ‚ฌ.

EPS history for Viking Therapeutics from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,86ย โ‚ฌ4.05%
2022-0,83ย โ‚ฌ26.39%
2021-0,66ย โ‚ฌ33.33%
2020-0,49ย โ‚ฌ45.95%
2019-0,34ย โ‚ฌ-5.13%
2018-0,36ย โ‚ฌ-51.25%
2017-0,73ย โ‚ฌ-20%
2016-0,91ย โ‚ฌ-64.08%
2015-2,54ย โ‚ฌ-45.17%
2014-4,63ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-9,34ย โ‚ฌ 1,001.08%๐Ÿ‡บ๐Ÿ‡ธ USA
1,91ย โ‚ฌ-324.73%๐Ÿ‡บ๐Ÿ‡ธ USA